Stem Cells

Stem cell therapy is the cutting edge 21st century medical treatment that can help prolong and improve your life, it can be the final solution to hopeless cases and is considered by many as the “fountain of youth”

Common Stem Cell Therapies

Stem cells are the essential building blocks of the human body. They are characterized by the ability to renew themselves through mitotic cell division and differentiate into diverge range of specialized cell types. Unlike a regular cell, which can only replicate to create more of its own kind, a stem cell is pluripotent – meaning it has the ability to develop into any one of the 220 different cells in the human body.

Stem cells are the precursors of specialized cells, such as blood, skin, liver, mucosa and other cell constitution tissues of the body.  Serving as a repair system in the body, stem cells can asymmetrically divide producing a mother cell which ensures self- replication, and a new cell is able to differentiate into a specialized cell.

Stem cells are considered to be a medical breakthrough because of their unique potential for replenishing and healing damaged cells and tissues of your body, while also proving to be an effective alternative to various surgical procedures and/or toxic treatments. Doctors and research scientists across the world have been examining various stem cell treatment modalities for several decades. The field of stem cell research is still in its infancy, however, a number of methods of treatment have emerged for use in humans:

  • Animal Stem Cells (commonly sheep and cattle)
  • Plant Stem Cells (extracted from organic material)
  • Adult Stem Cells (extracted from fat, bone-marrow and blood samples)
  • Fetal or Embryonic Stem Cells (considered unethical by many groups)
  • Amniotic Stem Cells (noninvasive for mom and  captured before birth of baby)

Why Use Amniotic Stem Cells?

Amniotic fluid surrounds the fetus during pregnancy and provides protection and nourishment. Treatment with amniotic fluid stem cells offer access to pristine and newly conceived cells compared to using non-human stem cells or those from aging and/or diseased patients. During the second half of gestation, most of the amniotic fluid is a result of micturition creating carbohydrates, proteins and peptides, fats, amino acids, enzymes, hormones, pigments and fetal cells. Amniotic fluid is a source of pluripotent stem cells which are the most basic cells living in the human body. Their most amazing trait is that they can be cultured and are capable of differentiation into 220 types of cells from skin to muscle, bone, organs, etc.

The Incredible Properties of Stem Cells Derived From Amniotic Rich Fluid

  1. Contain a higher concentration of stem cells  than bone marrow in adults,
  2. Are immune-privileged so there is no rejection factor,
  3. Contain excellent properties for promoting tissue regeneration and repair,
  4. Have important anti-inflammatory properties including cytokines to help relieve pain,
  5. Contain growth factors which promote new tissue growth, and
  6. Contains hyaluronic acid that lubricates and promotes growth of new cartilage.

While this data is genuinely remarkable the good news about stem cell treatment keeps getting better. The patented customized formula of Dr. Wilson Gan’s creation available through BioCel Therapy at PINS is a world-class exceptionally unique treatment experience for the patient customized for their individual needs.

PINS: A Global Leader in BioCel Technology

Doctors and clinics globally utilizing amniotic fluid injections use website descriptions that clearly indicate they are injecting the amniotic fluid in its natural state. The stem cell treatment must be undertaken by a registered medical specialist with an in-depth knowledge/degree in bio-molecular therapeutics, knowledgeable in the latest developments in molecular and cellular biochemistry.  The Philippines Institute of Naturopathic Sciences (PINS) under the leadership of Medical Director, Dr. Wilson Gan with his expertise in biotechnological transfer for healing, utilizes Amniotic Fluid Stem Cells (AFS) in combination with his patented and customized technology. During Dr. Gan’s formulated process the AFS is concentrated to increase the number of pristine stem cells present in each injection. Dr. Gan’s extensive international training and experience in biotechnology permits him to customize the formula for patients by augmenting the standard AFS with specific proprietary ingredients. This permits Dr. Gan to customize the BioCel Therapy regime for each patient to compensate for a family history of cancer, heart disease, degenerative eye disease, etc.

Patents:

Dr. Gan holds seven patents in the Philippines for his revolutionary formulation and process of biotechnology to customize injections for each patient. Our clinic is unaware of any doctor or facility anywhere doing work that compares with the ingenuity and customization of medical treatment provided by Dr. Wilson Gan. 

Summary:

Literature on human amniotic membrane injection for regenerative medicine is at a very early stage. Preliminary studies show promising results for the treatment. Dr. Gan has successfully treated patients for 15 years who have in the vast majority of cases have recovered from coma, stroke, heart attack, diabetes, cancer, paraplegia and many other conditions.  

Approved by Governing Bodies:

Amniotic fluids are considered to be minimally processed and not significantly changed in structure from the natural material. U.S. Food and Drug Administration (FDA) classify amniotic fluids/material as banked human tissue and therefore, it does not require FDA approval. These tissues are regulated by the American Association of Tissue Banks.

References:

1. Parolini O, Soncini M, Evangelista M, et al. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med. Mar 2009; 4(2):275-291.

2. Koob TJ, Rennert R, Zabek N, et al. Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing. Int Wound J. Oct 2013; 10(5):493-500.

3. Hanselman AE, Tidwell JE, Santrock RD. Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study. Foot Ankle Int. Feb 2015; 36(2):151-158.

4. Zelen CM, Poka A, Andrews J. Prospective, randomized, blinded, comparative study of injectable micronized dehydrated amniotic/chorionic membrane allograft for plantar fasciitis--a feasibility study. Foot Ankle Int. Oct 2013; 34(10):1332-1339.

Powered by Amazing-Templates.com 2014 - All Rights Reserved.